Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,227,820,098
-
Total 13F shares
-
264,228,568
-
Share change
-
-17,323,351
-
Total reported value
-
$12,767,462,065
-
Put/Call ratio
-
73%
-
Price per share
-
$48.23
-
Number of holders
-
720
-
Value change
-
-$860,043,070
-
Number of buys
-
287
-
Number of sells
-
368
Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q4 2024
As of 31 Dec 2024,
Sanofi - Common Stock and American Depositary Receipts (SNY) was held by
720 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
264,228,568 shares.
The largest 10 holders included
Dodge & Cox, Fisher Asset Management, LLC, Invesco Ltd., BANK OF AMERICA CORP /DE/, PRICE T ROWE ASSOCIATES INC /MD/, MORGAN STANLEY, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BlackRock, Inc., Boston Partners, and FMR LLC.
This page lists
724
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.